Hesperidin for COVID-19

Home COVID-19 treatment studies COVID-19 treatment studies COVID-19 studies Select treatmentSelect treatmentTreatmentsTreatments

Acetaminophen	Meta
Aspirin	Meta
Ibuprofen	Meta
Indomethacin	Meta
Close

Diet	Meta
Exercise	Meta
Sleep	Meta
Sun	Meta
Close

Antiandrogens..

All	Meta
Proxalutamide	Meta
Spironolactone	Meta
Close

Bamlaniv../e..	Meta
Bebtelovimab	Meta
Casirivimab/i..	Meta
Sotrovimab	Meta
Tixagev../c..	Meta
Close

Iota-carragee..

Vitamin A	Meta
Vitamin B9	Meta
Vitamin C	Meta
Vitamin D	Meta
Close

Other Treatments

Global Adoption

Hesperidin for COVID-19

Home

Global AdoptionAdoption

Submit FeedbackFeedback

Hesperidin has been reported as potentially beneficial for treatment of COVID-19. We have not reviewed these studies. See all other treatments.

Hesperidin, Hesperetin Submit Updates

Wang et al., Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology, Frontiers in Immunology, doi:10.3389/fimmu.2023.1185233

Abou Baker et al., An overview on medicinal plants used for combating coronavirus: Current potentials and challenges, Journal of Agriculture and Food Research, doi:10.1016/j.jafr.2023.100632

Toigo et al., Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies, DARU Journal of Pharmaceutical Sciences, doi:10.1007/s40199-023-00461-3

Srivastava et al., A Brief Review on Medicinal Plants-At-Arms against COVID-19, Interdisciplinary Perspectives on Infectious Diseases, doi:10.1155/2023/7598307

Bogoyavlenskiy et al., Computer Analysis of the Inhibition of ACE2 by Flavonoids and Identification of Their Potential Antiviral Pharmacophore Site, Molecules, doi:10.3390/molecules28093766

Giordano et al., Food Plant Secondary Metabolites Antiviral Activity and Their Possible Roles in SARS-CoV-2 Treatment: An Overview, Molecules, doi:10.3390/molecules28062470

Wu et al., Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods, Acta Pharmaceutica Sinica B, doi:10.1016/j.apsb.2020.02.008

England et al., Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19, Life, doi:10.3390/life13030617

Yang et al., A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity, Molecules, doi:10.3390/molecules28062735

Tallei et al., Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study, Scientifica, doi:10.1155/2020/6307457

Utomo et al., Revealing the Potency of Citrus and Galangal Constituents to Halt SARS-CoV-2 Infection, MDPI AG, doi:10.20944/preprints202003.0214.v1

Heleno et al., Plant Extracts and SARS-CoV-2: Research and Applications, Life, doi:10.3390/life13020386

Supianto et al., Cluster-based text mining for extracting drug candidates for the prevention of COVID-19 from the biomedical literature, Journal of Taibah University Medical Sciences, doi:10.1016/j.jtumed.2022.12.015

de Matos et al., Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review, Inflammation Research, doi:10.1007/s00011-022-01642-7

Jamalipour Soufi et al., Potential inhibitors of SARS-CoV-2: recent advances, Journal of Drug Targeting, doi:10.1080/1061186X.2020.1853736

Babu et al., Identification of differentially expressed genes and their major pathways among the patient with COVID-19, cystic fibrosis, and chronic kidney disease, Informatics in Medicine Unlocked, doi:10.1016/j.imu.2022.101038

Negru et al., Virtual Screening of Substances Used in the Treatment of SARS-CoV-2 Infection and Analysis of Compounds With Known Action on Structurally Similar Proteins From Other Viruses, Biomedicine & Pharmacotherapy, doi:10.1016/j.biopha.2022.113432

Qi et al., Discovery of TCMs and Derivatives Against the Main Protease of SARS-CoV-2 via High Throughput Screening, ADMET Analysis, and Inhibition Assay in Vitro, Journal of Molecular Structure, doi:10.1016/j.molstruc.2022.133709

Adem et al., Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105452

Ali et al., Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2, Archiv der Pharmazie, doi:10.1002/ardp.202100360

HELALİ et al., Natural substances and coronavirus: review and potential for the inhibition of SARS-CoV-2, Current Perspectives on Medicinal and Aromatic Plants (CUPMAP), doi:10.38093/cupmap.1029572

Mukherjee et al., Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications, Phytomedicine, doi:10.1016/j.phymed.2022.153930

https://www.mdpi.com/2072-6643/13/8/2800

https://www.sciencedirect.com/science/article/pii/S0223523421007066

https://www.mdpi.com/2304-8158/10/9/2084/htm

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.

Submit